• Business Wire

    Merz North America, Inc. and Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) , today announced that the first milestone payment related to their unique foam technology development program has been made to Foamix. “We are pleased with the continued progress of this program and our partnership with Foamix,” said Bill Humphries, President and Chief Executive Officer of Merz